Ashwagandha vs. Rhodiola: Which One the Evidence Backs

Short version: for the things people actually buy an adaptogen for — stress, anxiety, cortisol — ashwagandha has the better evidence, and it isn't close. Rhodiola's genuine edge is narrower and physical, and it shows up strongest as a single dose an hour before hard exercise. Every page ranking for this question tells the same tidy story — one calms you, one energizes you, pick your vibe — and the mechanism half of that is roughly right. The evidence half is not symmetric at all, and nobody says so. Worth knowing why: we sell neither herb, and there are no affiliate links on this page. Every other result currently ranking for this question is a company that sells one or both.

Ashwagandha vs. rhodiola at a glance

Two botanicals, not two products — so there are no scores or star ratings here. This is a spec sheet with our published evidence grades attached.

	Ashwagandha (Withania somnifera)	Rhodiola (Rhodiola rosea)
Part used	Root (sometimes root + leaf)	Root and rhizome
Key actives	Withanolides	Rosavins and salidroside
Typical standardization	5%+ withanolides (KSM-66); ~10% (Sensoril)	3% rosavins / 1% salidroside
Felt effect	Calming, sometimes sedating	Activating, sometimes over-stimulating
Best-supported claim	Stress and anxiety — grade B	Endurance performance — grade C
Cortisol evidence	B — repeated RCTs, serum cortisol	D — one unreplicated awakening-response finding
Anxiety evidence	B — RCTs plus a systematic review	D — no placebo-controlled anxiety trial
Sleep	C — modest, best at 600 mg for 8+ weeks	Not graded — no sleep trials; may worsen sleep if taken late
Typical studied dose	300–600 mg/day standardized root extract	200–600 mg/day; ~200 mg acutely pre-exercise
Timing	Often evening, with food	Morning or early afternoon
Safety ceiling studied	About 3 months	About 12 weeks
Notable risks	Rare liver injury; contraindicated in pregnancy; thyroid, sedative and immunosuppressant interactions	CYP2C9 drugs (warfarin, phenytoin); losartan; antidepressant case report; no pregnancy data

What each one actually is

Withania somnifera

Ashwagandha is the root of a small shrub used in Ayurveda, sold as a concentrated extract standardized to a family of steroidal compounds called withanolides. The species name gives away the direction of its effect: somnifera means sleep-inducing. Almost every positive trial tested a specific branded extract — KSM-66, Sensoril, Shoden — rather than generic root powder, which is why NIH's Office of Dietary Supplements concludes it is "difficult to identify specific extracts or recommended amounts."¹ Full benefit-by-benefit detail is on the ashwagandha hub.

Rhodiola rosea

Rhodiola — arctic root, golden root — grows in cold, high-altitude regions, and supplements use the root and rhizome.³ Its two marker compounds are rosavins and salidroside, and "3% rosavins / 1% salidroside" is the standardized extract spec suppliers sell to manufacturers.¹⁸ Rosavins are concentrated in R. rosea and absent from R. crenulata, the species most often substituted for it,¹⁸ which matters: the genus has dozens of species and the label is your only clue which one is in the bottle. Details and dosing sit on the rhodiola hub.

For stress and anxiety: not a close call

BModerate evidence Ashwagandha. ODS summarizes a 2021 systematic review of seven randomized trials in 491 adults, randomized to ashwagandha or placebo for 6 to 8 weeks, which found significant reductions in stress and anxiety on validated rating scales.¹ A larger 2022 meta-analysis of 12 trials in 1,002 participants found the same direction for both outcomes — and rated the certainty of that evidence low, with very high heterogeneity between studies.¹⁶ Two more caveats the marketing skips: all 491 adults in the ODS-summarized review were from India, and ashwagandha's own trial base is not unanimous — a 2025 meta-analysis pooling six trials on perceived stress found no significant effect on the Perceived Stress Scale, even while seven trials in the same paper showed a clear cortisol drop.⁵¹ That is what a B looks like: real, replicated, modest, and imperfect.

DInsufficient evidence Rhodiola, for anxiety. There is no placebo-controlled rhodiola anxiety trial. The two most-cited studies are a 10-person pilot in generalized anxiety disorder with no control group at all⁸ and an 80-person study whose comparison arm received no treatment rather than a placebo — the authors say so themselves and note they cannot establish a causal relationship.⁷ For stress and burnout specifically, rhodiola earns a C on the strength of a single 60-person placebo-controlled trial in stress-related fatigue.⁶

The clinical guideline reviewed both and split them. The WFSBP and CANMAT taskforce — 31 academics and clinicians across 15 countries — modestly supported ashwagandha in the treatment of anxiety disorders, and concluded that "rhodiola use was not supported for use in mood disorders."² ODS records the same taskforce provisionally recommending 300–600 mg/day of ashwagandha root extract standardized to 5% withanolides for generalized anxiety disorder, while noting more research is needed for a stronger recommendation.¹

One line that should not be lost in the grades: anxiety and depression are diagnosable conditions, and neither herb is a treatment for either. A clinician-facing guideline saying a botanical is "provisionally recommended" inside a medical care model is not the same as a supplement fixing an anxiety disorder. If that is what you are dealing with, the right next step is a clinician, not a capsule. Our stress and anxiety guide draws that line in more detail. This page is educational information, not medical advice.

Does rhodiola lower cortisol?

This is the single most repeated claim in this SERP, and it is not established.

Ashwagandha's cortisol case BModerate evidence is built on serum cortisol measured across multiple randomized trials.¹ The most-cited is a 60-day trial in chronically stressed adults on 600 mg/day of a full-spectrum root extract, which measured a 27.9% reduction in serum cortisol from baseline against 7.9% on placebo (P = 0.002).⁴ The 2025 meta-analysis mentioned above pooled seven trials and found a significant cortisol reduction of 1.16 µg/dL.⁵

Rhodiola's cortisol case DInsufficient evidence is one trial. In 2009, 60 people with fatigue syndrome took a proprietary extract or placebo for 28 days; among several outcomes, the salivary cortisol response to waking differed between groups.⁶ Three things about that. It is a different measurement from serum cortisol — a curve after waking, not a circulating level. It sat among a set of secondary outcomes in a trial where both arms improved substantially on the main scales, which is the signature of a large placebo effect. And in the seventeen years since, nobody has replicated it.

So: "rhodiola lowers cortisol" is not established — which is a different claim from "disproven." Nobody has shown it doesn't. Nobody has shown it does, either, and that distinction is the entire difference between a B and a D.

For energy and endurance: rhodiola's real edge

Here rhodiola wins, and the win is specific rather than sweeping.

A 2025 meta-analysis of 26 randomized trials in 668 healthy participants found small but significant improvements across endurance outcomes: VO₂max (pooled from 11 of those trials, effect size 0.32), time to exhaustion (7 trials, 0.38) and time-trial performance (5 trials, −0.40), alongside lower creatine kinase and blood lactate.⁹ Note the subsets — the headline "26 trials" never all measured the same thing, and the authors flag that only one of their analyses drew on more than 10 studies.⁹

The nuance no competing page carries: acute beats chronic. A 2023 systematic review of 13 trials in 263 participants concluded that acute rhodiola improved endurance performance and perceived exertion while chronic supplementation did not improve endurance performance.¹⁰ The cleanest demonstration is a 2004 crossover trial that tested both in the same people: 200 mg one hour before exercise raised time to exhaustion, and four weeks of daily 200 mg "did not alter any of the variables measured."¹¹

And the honest size of it. In that 2004 trial the time-to-exhaustion gain was 16.8 to 17.2 minutes — about 24 seconds on a 17-minute test.¹¹ It stays a C: individual trials are tiny, often around 10 to 13 people per arm, and a separate systematic review flagged unclear or high risk of bias in most of the studies it included.¹⁰ For fatigue rather than performance, the best-designed independent trial went the other way — 48 nursing students on shift work took rhodiola or placebo for 42 days, and placebo won on both fatigue measures.¹²

Ashwagandha's performance evidence is also a C, but it is a different and thinner C: a handful of small resistance-training and endurance studies at widely varying doses and extracts, with no pooled endurance estimate behind it. Same letter, not the same quality inside the band. If the goal is a hard session on Saturday, rhodiola is the better-supported pick.

Sleep, and the one part of the calming-vs-stimulating story that holds up

Ashwagandha has modest sleep evidence — a C, best at 600 mg/day for at least eight weeks, and most pronounced in people with insomnia.¹ Rhodiola has none: NCCIH's position is that there isn't enough reliable evidence to determine whether rhodiola is useful for any health-related purpose, and there is no sleep grade to give.³ What rhodiola does have is insomnia on its side-effect list.³ An evening rhodiola dose is a plausible way to sleep worse, which is why the traditional split — rhodiola early, ashwagandha late — is the one part of the popular framing that survives contact with the evidence.

Safety: the trade nobody mentions

This is the section where the asymmetry reverses, and it is the most interesting paragraph on the page. The better-evidenced herb also carries the more serious documented harms.

Ashwagandha. NIH's LiverTox database rates it a likelihood score of B — a likely cause of clinically apparent liver injury. Injury typically appears 2 to 12 weeks after starting, usually as jaundice and itching, and in most instances subsides within 1 to 4 months of stopping; rare fatal cases and cases requiring emergency liver transplantation have been reported, particularly in people with pre-existing liver disease.¹³ Pregnancy is a contraindication rather than a caution — some reports suggest a potential to cause spontaneous abortion, Denmark banned it in supplements in 2023, and France's ANSES recommended against use in pregnant and breastfeeding women in 2024.¹ It also interacts with thyroid medication, sedatives, immunosuppressants, antidiabetes drugs and antihypertensives, and ODS describes it as well tolerated for up to about 3 months with long-term safety unknown.¹ The case-by-case detail is in our guide to ashwagandha side effects.

Rhodiola. NCCIH calls it possibly safe for up to 12 weeks, with side effects that may include dizziness, headache, insomnia, and either dry mouth or excess saliva; it also notes reported interactions with losartan, a blood-pressure drug.³ A human crossover study in 13 volunteers found 14 days of a commercial rhodiola product reduced CYP2C9 activity by 21%, which the authors called potentially clinically relevant for narrow-therapeutic-index drugs like warfarin and phenytoin.¹⁴ Memorial Sloan Kettering flags the same two drugs, and lists a case report of tachyarrhythmia in a 26-year-old woman who took rhodiola alongside her antidepressant for three days.¹⁵ For pregnancy and breastfeeding, NCCIH's answer is that little is known.³

Read those two paragraphs side by side and the honest conclusion is uncomfortable: ashwagandha is better studied for benefit and better documented for harm, while rhodiola looks gentler largely because fewer people have looked. Absence of evidence is not evidence of safety.

Can you take ashwagandha and rhodiola together?

Yes, in the narrow sense that no direct interaction between the two has been documented, and the pairing logic — one calming, one activating — is coherent. Three things the "they're complementary!" answer leaves out:

If you're going to do it anyway, the defensible version is boring: run one at a time for four to six weeks before combining, stay inside the studied doses, rhodiola in the morning and ashwagandha in the evening, and clear it with a pharmacist if you take any regular medication. Keep in mind that the studied ceilings are short — about 12 weeks for rhodiola and about 3 months for ashwagandha — so an indefinite stack runs past the edge of what anyone has looked at.³¹

What about ginseng, holy basil or reishi?

We haven't graded them, so we're not going to rank them. Adding three ungraded botanicals to a comparison built on published evidence grades would make the page longer and the grades meaningless. When those hubs exist, they'll carry their own letters and this page will link to them.

The verdict: pick ashwagandha if… / pick rhodiola if…

Use case	Verdict	Why
Everyday stress	→ Ashwagandha	Seven-trial systematic review in 491 adults, significant reductions on validated scales (B vs C)
Anxiety symptoms	→ Ashwagandha	Rhodiola has no placebo-controlled anxiety trial; WFSBP/CANMAT supports ashwagandha, not rhodiola. Not a treatment for an anxiety disorder
Lowering cortisol	→ Ashwagandha	Serum-cortisol RCTs, including −27.9% over 60 days, vs. one unreplicated awakening-response finding (B vs D)
Sleep	→ Ashwagandha	Modest sleep evidence at 600 mg for 8+ weeks; rhodiola is activating and has none
Endurance / pre-workout energy	→ Rhodiola	26-trial meta-analysis on VO₂max, time to exhaustion and time trials; strongest acute, ~200 mg an hour before
Mental fatigue on a hard week	→ Toss-up, weakly rhodiola	Contradictory evidence, and the best independent trial favoured placebo. Set low expectations
Low mood	→ Neither	WFSBP/CANMAT: rhodiola not supported for mood disorders; we don't grade ashwagandha for depression. This is a clinical question
Pregnant or breastfeeding	→ Neither	Ashwagandha is contraindicated; rhodiola has no safety data
On warfarin, phenytoin, an SSRI or thyroid medication	→ Pharmacist first	Different interaction lists, both real

Frequently asked questions

The bottom line

If you're buying an adaptogen for the reason most people buy one — stress that won't switch off — buy ashwagandha, and buy it with your eyes open about the liver signal, the pregnancy contraindication and the three-month edge of the safety data. If you want something for a hard training block, rhodiola is the better-supported choice, taken acutely, with modest expectations. If you're pregnant, on warfarin or an SSRI, or dealing with something that looks more like a disorder than a rough month, the answer is neither, and the next step isn't a supplement.

The most telling number on this page isn't a p-value. A 2026 systematic review that examined both herbs together included 19 ashwagandha trials and 5 rhodiola trials.¹⁷ Nearly four to one. That ratio is the comparison, and no page selling both is ever going to print it.